Efficacy and Safety ofSanGrow Decoction for Patients With Diabetes
NCT ID: NCT02660593
Last Updated: 2016-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2016-03-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary Outcome Measures:
* Fast glucose and HbA1c change between the baseline and end of study \[ Time Frame: From baseline to 30 and 100 days\]
* \[ Designated as safety issue: No \]
* Successful rate of blood glucose control (the proportion of patients with HbA1c \<7%) \[ Time Frame: From baseline to 30 days and 100 days\] \[ Designated as safety issue: No \]
Secondary Outcome Measures:
• To evaluate the change of quality of life in the 1 months by the health questionnaire SF-36 \[ Time Frame: From baseline to month 1 \] \[ Designated as safety issue: No \]
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
NCT06964620
Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose
NCT05737342
Effect of Prebiotics on Blood Glucose Management
NCT04636489
Effects of Allium Hookeri on Blood Glucose
NCT03330366
The Effect of Korean Red Ginseng Supplementation on Glucose Control
NCT01911663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SanGrow
Patients will be given SanGrow Decoction 150 ml per day for 3 months.
SanGrow Decoction
SanGrow Decoction is perpared according to the principle of Chinese medicine to treat thirsty and maransis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SanGrow Decoction
SanGrow Decoction is perpared according to the principle of Chinese medicine to treat thirsty and maransis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients willing to sign written informed consent form
Exclusion Criteria
* Females who are pregnant or nursing or females of childbearing potential who are unwilling to maintain contraceptive therapy for the duration of the study
* Life expectancy \< 6 months due to concomitant illnesses.
10 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shidaihuajing Institute for Diabetic Research
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shizhan CHi, PhD
Role: STUDY_CHAIR
Shidaihuajing Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jiuhua Hospital
Beijing, Beijing Municipality, China
Xuanwu Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Chi Shizhan, Master
Role: primary
Chi Shizhan, Master
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SanGrow Decoction for diabetes
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.